Nanobodies dismantle post‐pyroptotic ASC specks and counteract inflammation in vivo
Open Access
- 19 April 2022
- journal article
- research article
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 14 (6) , e15415
Abstract
Inflammasomes sense intracellular clues of infection, damage, or metabolic imbalances. Activated inflammasome sensors polymerize the adaptor ASC into micron‐sized “specks” to maximize caspase‐1 activation and the maturation of IL‐1 cytokines. Caspase‐1 also drives pyroptosis, a lytic cell death characterized by leakage of intracellular content to the extracellular space. ASC specks are released among cytosolic content, and accumulate in tissues of patients with chronic inflammation. However, if extracellular ASC specks contribute to disease, or are merely inert remnants of cell death remains unknown. Here, we show that camelid‐derived nanobodies against ASC (VHH ASC ) target and disassemble post‐pyroptotic inflammasomes, neutralizing their prionoid, and inflammatory functions. Notably, pyroptosis‐driven membrane perforation and exposure of ASC specks to the extracellular environment allowed VHH ASC to target inflammasomes while preserving pre‐pyroptotic IL‐1β release, essential to host defense. Systemically administrated mouse‐specific VHH ASC attenuated inflammation and clinical gout, and antigen‐induced arthritis disease. Hence, VHH ASC neutralized post‐pyroptotic inflammasomes revealing a previously unappreciated role for these complexes in disease. VHH ASC are the first biologicals that disassemble pre‐formed inflammasomes while preserving their functions in host defense.Keywords
Funding Information
- H2020 European Research Council (PLAT‐IL‐1)
- H2020 European Research Council (714175)
- Deutsche Forschungsgemeinschaft (EXC 2151‐390873048)
- Deutsche Forschungsgemeinschaft (322568668)
- Deutsche Forschungsgemeinschaft (TRR237‐369799452)
This publication has 70 references indexed in Scilit:
- Rapid induction of inflammatory lipid mediators by the inflammasome in vivoNature, 2012
- Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59Proceedings of the National Academy of Sciences, 2011
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- IL-17 mediates articular hypernociception in antigen-induced arthritis in micePain, 2010
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trialsAnnals of the Rheumatic Diseases, 2009
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinraAnnals of the Rheumatic Diseases, 2007
- Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs)Journal of Immunological Methods, 2007
- The pyroptosome: a supramolecular assembly of ASC dimers mediating inflammatory cell death via caspase-1 activationCell Death & Differentiation, 2007
- The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean feverEuropean Journal of Pediatrics, 2007